Sanofi (SNY), Regeneron (REGN) Update on Two Phase 1b Dupilumab Trials
Go back to Sanofi (SNY), Regeneron (REGN) Update on Two Phase 1b Dupilumab Trials| Regeneron (NASDAQ: REGN) | Delayed: 656.01 +4.10 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $651.91 | 52 Week High | $592.36 | |||
| Open | $658.29 | 52 Week Low | $325.35 | |||
| Day High | $667.50 | P/E | 172.18 | |||
| Day Low | $654.05 | EPS | $3.81 | |||
| Volume | 708,393 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.35 -0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.36 | 52 Week High | $44.76 | |||
| Open | $43.16 | 52 Week Low | $36.81 | |||
| Day High | $43.49 | P/E | N/A | |||
| Day Low | $42.94 | EPS | $0.00 | |||
| Volume | 3,067,633 | |||||

